Compare GRFS & HLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GRFS | HLNE |
|---|---|---|
| Founded | 1940 | 1991 |
| Country | Spain | United States |
| Employees | 23800 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 6.7B |
| IPO Year | N/A | 2017 |
| Metric | GRFS | HLNE |
|---|---|---|
| Price | $8.93 | $108.00 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $10.15 | ★ $168.33 |
| AVG Volume (30 Days) | 446.1K | ★ 694.8K |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | 1.54% | ★ 2.03% |
| EPS Growth | N/A | ★ 41.64 |
| EPS | N/A | ★ 3.98 |
| Revenue | N/A | ★ $712,963,000.00 |
| Revenue This Year | $5.47 | $9.81 |
| Revenue Next Year | $4.92 | $19.69 |
| P/E Ratio | ★ $18.67 | $26.47 |
| Revenue Growth | N/A | ★ 28.73 |
| 52 Week Low | $6.19 | $98.00 |
| 52 Week High | $11.14 | $179.19 |
| Indicator | GRFS | HLNE |
|---|---|---|
| Relative Strength Index (RSI) | 42.21 | 31.75 |
| Support Level | $8.66 | N/A |
| Resistance Level | $9.11 | $157.95 |
| Average True Range (ATR) | 0.29 | 6.58 |
| MACD | -0.05 | -2.28 |
| Stochastic Oscillator | 42.28 | 26.10 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Hamilton Lane Inc is a private markets investment firm globally, providing solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 750 professionals operating in offices throughout North America, Europe, Asia Pacific, and the Middle East. It has approximately $986 billion in assets under management and supervision, composed of nearly $141 billion in discretionary assets and more than $845 billion in non-discretionary assets. The group specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors, and geographies.